ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Analysts Slash Boeing Target by $50

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Barclays made one of the sharpest moves in today's batch. Anthony Valentini cut his target on BA from $300 to $250. He held his Buy rating despite the 17% target reduction. The stock remains in the buy camp for most analysts. 25 of 28 covering analysts still rate it a Buy.

UPS also drew attention from Barclays. Brandon Oglenski raised his target from $80 to $95. That is a meaningful 19% uplift. He still rates the stock a Sell, but the wider consensus is mixed: three Sells, 12 Holds, and 13 Buys.

On the upgrade side, Barclays raised its target on VEEV from $360 to $375 with a Buy rating. Saket Kalia backed the cloud software firm, which sits in a consensus of 18 Buys and just one Sell.

SPGI saw its consensus target nudge up from $515 to $523. S&P Global's analyst community remains overwhelmingly bullish. 22 of 23 covering analysts carry a Buy.

XYL got a target cut from RBC Capital. Jeffrey Reive trimmed from $135 to $125 while keeping a Buy. Xylem, the water technology company, carries 12 Buys and six Holds.

Sherwin-Williams SHW saw its consensus target edge down from $383 to $379. No rating change accompanied the move, with 15 Buys and 14 Holds among covering analysts.

Barclays lifted its V target from $420 to $440. Visa draws 36 Buys from analysts, with just two Sells in the entire coverage group.

Stocks in this article

How this article was generated

Generated
29 Oct 2026, 00:20
Prompt version
v1.0
Data sources
Analyst consensusAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.